![Figure 5 from Amyotrophic lateral sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) mutations in British Columbia, Canada : clinical, neurophysiological and neuropathological features | Semantic Scholar Figure 5 from Amyotrophic lateral sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) mutations in British Columbia, Canada : clinical, neurophysiological and neuropathological features | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14154c6a887a85a33b010e5100cf3001e2635026/45-Figure5-1.png)
Figure 5 from Amyotrophic lateral sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) mutations in British Columbia, Canada : clinical, neurophysiological and neuropathological features | Semantic Scholar
![Clinical cases of amyotrophic lateral sclerosis concurrent with hydromyelia - Bogdanov - 2021 - Clinical Case Reports - Wiley Online Library Clinical cases of amyotrophic lateral sclerosis concurrent with hydromyelia - Bogdanov - 2021 - Clinical Case Reports - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a8d7cc80-b1f6-43cc-a371-d552d26581f8/ccr33832-fig-0001-m.jpg)
Clinical cases of amyotrophic lateral sclerosis concurrent with hydromyelia - Bogdanov - 2021 - Clinical Case Reports - Wiley Online Library
![Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? | BMJ Case Reports Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship? | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2013/bcr-2012-007975/F1.large.jpg)